BioSpace News Archive

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the presentation of preclinical data on the company’s anti-CD27 agonist lead antibodies at the American Association for Cancer Research (AACR) Annual Meeting 2022.

The U.S. Food and Drug Administration issued a new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in the U.S. into clinical trials – expanding on the agency’s previous guidances for industry to improve clinical trial diversity.

With the increase in life expectancy in several countries, the prevalence of neurodegenerative diseases has considerable increased.

Human gamma delta T cells are unique innate immune cells which contribute to about 1%-5% of the lymphocytes in the peripheral blood.

Covid testing remains in high demand for the film and production industry.

Awakn Clinics Bristol was Awakn’s and the UK’s first medical psychedelic-assisted therapy clinic.

30 years of industry experience from CEO of Nasdaq-listed biotech to Vice President, Marketing at Pfizer.

APTI has been informed that the first set of claims from US patent application 16/180,960 have been allowed.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), today announced positive preclinical data demonstrating potent T cell responses, potential novel combination use beyond PD-1 inhibitors, and the ability to break immune tolerance to various self-antigens for targeting cancers.

AbbVie today announced that the AbbVie Cystic Fibrosis (CF) Scholarship program is now accepting applications for the 2022-2023 academic school year.